NCT04855513 - Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial | Biotech Hunter

Enrollment

414

Participants

Timeline

Start Date

March 24, 2022

Primary Completion Date

April 24, 2023

Study Completion Date

December 30, 2023

Conditions

PreeclampsiaPreeclampsia SevereHigh Risk PregnancyEclampsia

Interventions

DRUG

Metformin

Metformin is a medication used for treatment of diabetes. In this study it will be used to explore is potential role in prevention of preeclampsia. The drug will start before 12 week of pregnancy and continue till delivery

Trial Locations (1)

3050

Women Wellness and Research Center, Doha